Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital

International Journal of Clinical Pharmacy

Volumn 35, Issue 5, 2013, Pages 736-743

  Thanimalai, Subramaniam ^a,b   Shafie, Asrul Akmal ^b   Hassali, Mohamed Azmi ^b   Sinnadurai, Jeyaindran ^a  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Anticoagulation clinic; Malaysia; Pharmacists; Therapeutic range; Warfarin

Indexed keywords

WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL PERSONNEL; PHARMACIST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THROMBOEMBOLISM; URINARY TRACT HEMORRHAGE; VAGINA BLEEDING;

AGED; ANTICOAGULANTS; COHORT STUDIES; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALAYSIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, BIOLOGICAL; OUTPATIENT CLINICS, HOSPITAL; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; POINT-OF-CARE SYSTEMS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK; TERTIARY CARE CENTERS; THROMBOEMBOLISM; WARFARIN;

EID: 84886088419     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9796-6     Document Type: Article

References (30)

1. Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol. 2006;62(5):509-11.
2. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414-9.
3. Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(11):2418-27.
4. Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24(10):1021-33.
5. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest. 2001;119(1 Suppl):22S-38S.
6. Bungard TJ, Gardner L, Archer SL, Hamilton P, Ritchie B, Tymchak W, et al. Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Med. 2009;3(1):e16-21.
7. Donovan JL, Drake JA, Whittaker P, Tran MT. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis. 2006;22(1):23-30.
8. You JH, Chan FW, Wong RS, Cheng G. Cost-effectiveness of two models of management for patients on chronic warfarin therapy - a Markov model analysis. Thromb Haemost. 2003;90(6):1106-11.
9. Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, Permsuwan U. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm. 2012;34(1):105-12.
10. Choe H, Kim J, Choi K, Mueller B. Implementation of the first pharmacist-managed ambulatory care anticoagulation clinic in South Korea. Am J Health-Syst Pharm. 2002;59(9):872-4.
11. Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial. Br J Clin Pharmacol. 2006;62(5):601-9.
12. Kong MC, Ng HJ, Lee PL, Chan YH, Tan D, Lee LH. Implementation and impact of a hybrid pharmacist-assisted anticoagulation clinic model on the quality of anticoagulation therapy. Clin Appl Thromb Hemost. 2012;18(3):334-7.
13. Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res. 2005;5(1):21.
14. Government of Malaysia. Pekeliling Perkhidmatan. In: Malaysia PSDo, editor. Putrajaya; 2007. p. 1-545.
15. Medication Therapy Adherence Clinic. Warfarin. First Edition 2010. Kuala Lumpur: Perpustakaan Negara Malaysia; 2010.
16. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(1 Suppl):8S-21S.
17. Fitzmaurice DA, Blann AD, Lip GYH. Bleeding risks of antithrombotic therapy. BMJ. 2002;325(7368):828-31.
18. Wilson SJ-A, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Can Med Assoc J. 2003;169(4):293-8.
19. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-9.
20. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):160S-98S.
21. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract. 2001;14(1):16-21.
22. Hwang JM, Clemente J, Sharma KP, Taylor TN, Garwood CL. Transportation cost of anticoagulation clinic visits in an urban setting. J Manag Care Pharm. 2011;17(8):635-40.
23. Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O'Shea P. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Fam Pract. 2011;12(88):1471-2296.
24. Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007;32(1):21-9.
25. Thanimalai S CT, Ariffin F, Chan CK, Chan BS, Chong SH, Heng SY. Achieving INR targets and improving satisfaction of Warfarinized patients, Kuala Lumpur Hospital. J Quality Improvement. 2010;2:50-67 [Original Article].
26. Cindy J, Guy L. Enhancing patient care via a pharmacist-managed rural anticoagulation clinic. Healthc Q. 2009;13(Sp):69-74.
27. Lodwick AD, Sajbel TA. Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care. 2000;9(2):47-50.
28. Jowett S, Bryan S, Mahe I, Brieger D, Carlsson J, Kartman B, et al. A multinational investigation of time and travelling costs in attending anticoagulation clinics. Value Health. 2008;11(2):207-12.
29. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Quality Outcomes. 2008;1(2):84-91.
30. Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010;30(4):330-8.